Researcher
Bart Ghesquière
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Cancer biology, (Bio)molecular modelling and design, Analytical biochemistry, Auto-ecology, Biogeography and phylogeography, Anthropological genetics, Bacteriology, Cell death and senescence, Epigenomics, Environmental safety and health of nanotechnology, Medical biophysics, General diagnostics, Adaptive immunology, Behavioural neuroscience
- Disciplines (KU Leuven):Metabolomics, Separation techniques, Spectrometry, Regulation of metabolism
- See also: Ghesquiere Bart (Flanders Institute for Biotechnology)
Affiliations
- Metabolomics Expertise Center (VIB-KU Leuven) (Division)
Responsible
From1 Oct 2016 → Today - VIB Metabolomics Core Leuven (Core Lab)
Responsible
From1 Sep 2017 → Today - VIB-KU Leuven Center for Cancer Biology (Research Center)
Responsible
From1 Sep 2017 → Today - Ghesquière Lab (Research group)
Responsible
From1 Sep 2017 → Today - VIB Metabolomics Core Leuven (Core Lab)
Responsible
From1 Jan 2017 → Today - Metabolomics Expertise Center (VIB-KU Leuven) (Division)
Member
From1 Oct 2016 → 30 Sep 2022 - Laboratory of Angiogenesis and Vascular Metabolism (VIB-KU Leuven) (Division)
Member
From1 Jan 2012 → 30 Sep 2014
Infrastructure
1 - 1 of 1
Projects
1 - 10 of 17
- Association of perfusate metabolome during normothermic liver perfusion with post-transplant outcomesFrom1 Aug 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Association of perfusate metabolomic profile during normothermic kidney perfusion with post-transplant outcomesFrom1 Aug 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- A novel hybrid metabolomics platform combining the power of gas chromatography separation with highresolution, high-accuracy mass spectrometry of full precursor masses.From1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- Optimising hypothermic kidney graft perfusion preservationFrom1 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Metabolic rewiring in SORDD polyneuropathy: unraveling a polyol pathway disorderFrom1 Oct 2021 → TodayFunding: FWO fellowships
- Metabolomics as a tool for developing therapies in an endothelial cell model of congenital disorders of glycosylationFrom20 Sep 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Studying congenital disorders of glycosylation and their potential treatments using tracer metabolomicsFrom24 Sep 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Translational research-oriented technology platform for single cell analysisFrom1 May 2020 → TodayFunding: BOF - scientific equipment program
- Galactose rewires metabolism in the treatment of congenital disorders of glycosylation.From1 Jan 2020 → 31 Dec 2023Funding: FWO research project (including WEAVE projects)
- Metabolomic viability fingerprint during normothermic isolated kidney perfusion using tracer metabolomicsFrom1 Oct 2018 → 30 Sep 2022Funding: FWO fellowships
Publications
21 - 30 of 108
- Unraveling metabolism during kidney perfusion using tracer studies, a systematic review.(2022)
Authors: Julie De Beule, Bart Ghesquière, Ina Jochmans
Pages: 2118 - 2134 - RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition(2022)
Authors: Bart Ghesquière
- TraVis Pies: A Guide for Stable Isotope Metabolomics Interpretation Using an Intuitive Visualization(2022)
Authors: Karen Driesen, Bart Ghesquière
- How tech-savvy employees make the difference in core facilities Recognizing core facility expertise with dedicated career tracks(2022)
Authors: Bart Ghesquière, Sebastian Munck
- Lipid droplet degradation by autophagy connects mitochondria metabolism to Prox1-driven expression of lymphatic genes and lymphangiogenesis(2022)
Authors: Diede Houbaert, Maria Livia Sassano, Mila Borri, Jelle Verhoeven, Madhur Agrawal, Gabriele Bergers, Bart Ghesquière, Mieke Dewerchin, Johan Swinnen, Peter Carmeliet, et al.
- The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming(2022)
Authors: Bart Ghesquière
Pages: 516 - + - METABOLIC ALTERATIONS DURING CHONDROGENIC DIFFERENTIATION IN SPHEROIDS: TOWARDS IDENTIFICATION OF METABOLIC MARKERS FOR ENDOCHONDRAL OSSIFICATION.(2022)
Authors: Niki Loverdou, Kristel Bernaerts, Bart Ghesquière, Geert Carmeliet, Ioannis Papantoniou, Liesbet Geris
Pages: S445 - S445 - TRAPPC9-CDG: A novel congenital disorder of glycosylation with dysmorphic features and intellectual disability(2022)
Authors: Bart Ghesquière, Peter Witters
Pages: 894 - 904 - Antizyme Inhibitor 1 Regulates Matrikine Expression and Enhances the Metastatic Potential of Aggressive Primary Prostate Cancer(2022)
Authors: Lisa Moris, Bram Boeckx, Diether Lambrechts, Christine Helsen, Bart Ghesquière, Stefaan Soenen, Elien Smeets, Roy Eerlings, Sarah El Kharraz, Hendrik Van Poppel, et al.
Pages: 527 - 541 - Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis(2022)
Authors: Bart Ghesquière
Patents
1 - 2 of 2